At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Tomato Consumption on Serum High Density Lipoprotein-cholesterol Levels. A Randomized, Open-label, Single Blind, Clinical Trial
In Brief
A clinical study evaluating Tomato consumption and Cucumber consumption for Hypoalphalipoproteinemia. Completed, enrolled 50 participants across 1 site.
Detailed Summary
* This is a randomized, open-label, single blind, clinical trial * The study evaluated the effect of tomato consumption in serum HDL-cholesterol levels. * The hypothesis was that two daily tomatoes during one month will increase the HDL-c levels. * Since a placebo of tomatoes cannot be done, the control group will receive same proportion of cucumber because 1) it was not possible to have a tomato placebo; 2) cucumber does not have any lycopene; 3) both can be prepared similarly; and 4) the required quantity can be measured in the same way. * The intervention was during 1 month and was assigned by randomization. * Personnel who did the clinical and biochemical evaluation were blinded for the intervention. * Lipid profile was measured before and after the intervention. * Confounding factors such as daily physical activity, diet, consumption of fish or alcoholic beverages, smoking status were considered during statistical analyses.
Study Details
Timeline
Interventions
Daily consumption of 300g of uncooked roma tomatoes during one month.
Daily consumption of 300g of cucumber.